Mar Forner graduated in BSc Chemistry (2013) and MSc Biomedicine (2015) at the University of Barcelona. Since September 2015, she is a Biomedicine PhD candidate in Prof David Andreu’s group at the Pompeu Fabra University (UPF), funded by MINECO AGL2014-52395-C2-2-R and BES-2015-071843. Her research interest lies in modulating peptides to obtain biological applications. In 2014, she worked with Dr Laura Nevola in Prof Ernest Giralt laboratory and participated in a project aimed at modulating protein-protein interactions (PPIs) by peptidomimetics at the Institute for Research in Biomedicine Barcelona (IRB, Barcelona). Currently, as PhD student, she is involved in peptide-based synthetic vaccines project focus on developing multi-epitope peptide platforms against foot-and-mouth disease (FMD). To synthesize and characterize the peptides, she uses solid phase peptide synthesis (SPPS), Liquid Chromatography (HPLC), Mass Spectrometry (MS), Circular Dichroism (CD) and Nuclear Magnetic Resonance Spectroscopy (NMR). In 2018, she was seconded to Dr Sónia Henriques at the Institute of Health and Biomedical Innovation (IHBI) within Translational Research Institute (TRI) and Prof David Craik’s group at the University of Queensland – the Institute for Molecular Bioscience (UQ-IMB) by MSCA-RISE-2014 INPACT in a project titled “Uptake, distribution and localization studies of multi-epitope peptide based anti-infective vaccines”. She used a wide range of techniques such as surface plasmon resonance (SPR), flow cytometry and confocal microscopy to examine the cellular uptake and the mode-of-action of the peptide constructions.